Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes Tegoprubart to be Used as Immunosuppressive Agent in Cohort C of Sernova's Phase 1/2 Cell Pouch Bio-hybrid Organ Clinical Trial in Patients with Type 1 Diabetes GlobeNewswire July 09, 2025 LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) — […]

FST Corp. Announces Expansion of Fulfillment Center in Garden Grove, California GlobeNewswire July 09, 2025 BOULDER, CO, July 09, 2025 (GLOBE NEWSWIRE) — FST Corp. (Nasdaq: KBSX), a leading manufacturer and marketer of steel and graphite golf shafts and a provider of other golf-related services, today announced it has approved plans to expand its fulfillment

TRIMEDX ranked 30th Inspiring Workplace in North America and recognized as Best in Class Leadership Recognition builds on 2024 honor, reinforces commitment to PeopleFirst culture and exceptional leadership across the healthcare industry GlobeNewswire July 09, 2025 Indianapolis, Indiana, July 09, 2025 (GLOBE NEWSWIRE) — TRIMEDX―a leading independent clinical asset management company delivering clinical engineering services,

MDWerks' Two Trees Beverage Subsidiary Receives Three 2025 SIP Awards GlobeNewswire July 09, 2025 GREEN COVE SPRINGS, Fla., July 09, 2025 (GLOBE NEWSWIRE) — MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that its subsidiary, Two Trees Beverage Company (“Two Trees”),

Live Oak Bancshares, Inc. Announces Date of Second Quarter 2025 Financial Results GlobeNewswire July 09, 2025 WILMINGTON, N.C., July 09, 2025 (GLOBE NEWSWIRE) — Live Oak Bancshares, Inc. (NYSE: LOB) today announced that it will report its second quarter 2025 financial results after U.S. financial markets close on Wednesday, July 23, 2025. In conjunction with

Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045 Application Update Based on Extensive Review of Data GlobeNewswire July 09, 2025 GLEN ALLEN, Va., July 09, 2025 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company

Stantec to release second quarter 2025 results on August 13, 2025 and host conference call on August 14, 2025 GlobeNewswire July 09, 2025 EDMONTON, Alberta, July 09, 2025 (GLOBE NEWSWIRE) — TSX,NYSE: STN Stantec, a global leader in sustainable design and engineering, will release its second quarter 2025 financial results after markets close on Wednesday,

AI-Powered Manufacturing in the U.S. Set for $6.08 Billion Market by 2028 GlobeNewswire July 09, 2025 Delray Beach, FL, July 09, 2025 (GLOBE NEWSWIRE) — The report “Artificial Intelligence in Manufacturing Market by Offering (Hardware, Software, Services), Technology (Machine Learning, Natural Language Processing), Application (Predictive Maintenance & Machinery Inspection, Cybersecurity) – Global Forecast to 2028″

Alpha Modus Awarded New U.S. Patent Strengthening Its AI Retail Technology Portfolio Poised for Immediate Commercial Deployments and Licensing Opportunities GlobeNewswire July 09, 2025 CORNELIUS, N.C., July 09, 2025 (GLOBE NEWSWIRE) — Alpha Modus Holdings, Inc. (NASDAQ: AMOD), a pioneer in AI-powered retail technology and data-driven innovation, is pleased to announce the issuance of U.S.

Silexion Therapeutics Announces Positive Results in Preclinical Study Demonstrating Significant SIL204 Efficacy in Human Lung Cancer Cell Lines Company's New Groundbreaking Preclinical Data in NSCLC Models Provides Further Validation for SIL204's Innovative Delivery System; Company is Currently Conducting Additional Studies into New and Previously Untested KRAS Mutation with Results expected in the Near Future GlobeNewswire